Recombinant factor VIIa for the treatment of exsanguinating trauma patients: A matched-pair analysis from the Trauma Registry of the German Society for Trauma Surgery;Rekombinanter Faktor VIIa in der Hämorrhagiebehandlung des Schwerstverletzten: Eine Matched-pair-Analyse anhand des TraumaRegisters der Deutschen Gesellschaft für Unfallchirurgie

Unfallchirurg

Volumn 116, Issue 6, 2013, Pages 524-530

  Wafaisade, A ^a   Lefering, R ^b,c   Maegele, M ^a   Helm, P ^a   Braun, M ^a   Paffrath, T ^a   Bouillon, B ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c Sektion Notfall und Intensivmedizin und Schwerverletztenversorgung   (Germany)

Author keywords

Bleeding Transfusion; Mortality; Recombinant factor VIIa; Trauma

Indexed keywords

BLOOD CLOTTING FACTOR 7A; HEMOSTATIC AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; COMORBIDITY; EXSANGUINATION; FEMALE; GERMANY; HUMAN; INJURY; MALE; MORTALITY; PREVALENCE; REGISTER; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME; EPIDEMIOLOGY; WOUNDS AND INJURIES;

ADULT; BLOOD TRANSFUSION; COMORBIDITY; EXSANGUINATION; FACTOR VIIA; FEMALE; GERMANY; HEMOSTATICS; HUMANS; MALE; MATCHED-PAIR ANALYSIS; PREVALENCE; RECOMBINANT PROTEINS; REGISTRIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 84873411703     PISSN: 01775537     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00113-011-2146-z     Document Type: Article

References (23)

1. Association for the Advancement of Automotive Medicine (1990) The abbreviated injury scale 1990 revision. Association for the Advancement of Automotive Medicine, Des Plaines, IL, USA
2. Baker SP, O'Neill B, Haddon W Jr et al (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14:187-196
3. Boffard KD, Riou B, Warren B et al (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59:8-15
4. Bogner V, Mutschler W, Biberthaler P (2009) Der Faktor "Zeit". Seine Bedeutung in der Pathophysiologie und Therapie des Polytraumas. Unfallchirurg 112:838-845
5. Bouillon B, Rixen D, Maegele M et al (2009) Damage control orthopedics. Was ist der aktuelle Stand? Unfallchirurg 112:860-869
6. Flohe S, Nast-Kolb D (2009) Chirurgisches Management vital bedrohlicher Verletzungen. Unfallchirurg 112:854-859
7. Hauser CJ, Boffard K, Dutton R et al (2010) Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 69:489-500
8. Holcomb JB, Jenkins D, Rhee P et al (2007) Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 62:307-310
9. Huber-Wagner S, Lefering R, Qvick LM et al (2009) Effect of whole-body CT during trauma resuscitation on survival: a retrospective, multicentre study. Lancet 373:1455-1461
10. Kauvar DS, Lefering R, Wade CE (2006) Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 60:3-11
11. Kenet G, Walden R, Eldad A et al (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879
12. Kobbe P, Lichte P, Wellmann M et al (2009) Techniken der Wiedererwärmung bei hypothermen Schwerverletzten. Unfallchirurg 112:1062-5
13. Maegele M, Lefering R, Yucel N et al (2007) Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 38:298-304
14. McMullin NR, Wade CE, Holcomb JB et al (2010) Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes. J Trauma 69:60-69
15. Ruchholtz S, Lefering R, Paffrath T et al (2008) Reduction in mortality of severely injured patients in Germany. Dtsch Arztebl Int 105:225-231
16. Arbeitsgemeinschaft "Scoring" der Deutschen Gesellschaft für Unfallchirurgie (1994) Das Traumaregister der Deutschen Gesellschaft für Unfallchirurgie. Unfallchirurg 97:230-237
17. Spinella PC, Perkins JG, McLaughlin DF et al (2008) The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma 64:286-293
18. Stein DM, Dutton RP, O'Connor J et al (2008) Determinants of futility of administration of recombinant factor VIIa in trauma. J Trauma 59:609-615
19. Vincent JL, Mendonca A de, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26:1793-1800
20. Vincent JL, Rossaint R, Riou B et al (2006) Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding-A European perspective. Crit Care 10:R120
21. Wade CE, Eastridge BJ, Jones JA et al (2010) Use of recombinant factor VIIa in US military casualties for a five-year period. J Trauma 69:353-359
22. Wafaisade A, Lefering R, Tjardes T et al (2010) Acute coagulopathy in isolated blunt traumatic brain injury. Neurocrit Care 12:211-219
23. Waydhas C, Gorlinger K (2009) Gerinnungsmanagement beim Polytrauma. Unfallchirurg 112:942-950